Cochrane Library Podcasts

The Cochrane Developmental, Psychosocial and Learning Problems Group produced several reviews relevant to the treatment of attention deficit hyperactivity disorder and the update for one of these, investigating the drug methylphenidate, was published in March 2023. Here's one of the authors, Maja Storm from the Psychiatric Research Unit, Region Zealand in Denmark, to tell us about the latest evidence.

Carpal tunnel syndrome is a common condition that affects people worldwide. There are several Cochrane reviews and these were added to in February 2023 with a new review of corticosteroid injections. Here's lead author, Nigel Ashworth from the University of Alberta in Canada, to tell us about the findings.

For some health conditions, there are multiple Cochrane reviews, each looking at the effects of a different intervention. Overviews of reviews are intended to help users to consider all interventions together and one of these overviews, for treating pain and disability in adults with complex regional pain syndrome was updated in June 2023. Here's lead author, Michael Ferraro from Neuroscience Research Australia, to describe the findings.

Alongside their reviews on treatments for chronic kidney disease, the Cochrane Kidney and Transplant Group produce reviews for interventions that might help with its consequences. These were added to in August 2023 with a new review of ways to help manage the fatigue experienced by people requiring dialysis. Here's lead author, Patrizia Natale from the University of Sydney in Australia, to tell us about the review.

People with diabetes face additional challenges when they need treatments, such as surgery, for other conditions. In the August 2023 update to the Cochrane review, reviewers examined whether perioperative glycaemic control might help with this, and we asked joint lead author, Dídac Mauricio from the CIBER of Diabetes and Associated Metabolic Disease in Barcelona Spain to tell us more in this podcast.

The Cochrane Pain, Palliative and Supportive Care Group has produced more than 300 reviews and added to these in August 2023 with a review of remotely-delivered psychological therapies for chronic pain in adults. Here's one of the authors, Geoff Duggan formerly from the Bath Centre for Pain Services in the UK, to tell us about the importance of the review and its findings.

There are several Cochrane Reviews of methods to ensure that blood transfusions are used effectively and efficiently, and that donated blood remains available for use in emergency situations. One of the first of these reviews looked at the evidence on a technique called cell salvage. It was first published in October 2003 and the fourth update appeared in September 2023. We asked new lead author, Louise Geneen from NHS Blood and Transplant based in Oxford UK, to tell us more about the technique and the latest findings of the review.

The Cochrane Breast Cancer Group have published reviews on more than 80 topics, and these were added to in September 2023 with a review of platinum-based chemotherapy for women with early stage triple negative breast cancer. In this podcast, Rachel Dear, co-author and breast cancer oncologist based in Sydney, talks with lead author, Sofia Mason from the Garvan Institute of Medical Research in Darlinghurst Australia about the findings.

In this podcast, we're delving into the topic of "Healthy Eating Interventions in Early Childhood Education and Care Settings", which is especially important because helping children to develop healthy eating habits early on can greatly influence their dietary choices later in life. Here’s one of the authors, Melanie Lum, talking with lead author, Serene Yoong from Deakin University in Australia about the June 2023 Cochrane review of 52 randomized trials.

Effective management of a patient's pain is a key part of cancer care and various medicines have been suggested to help with this. These include cannabis-based medicines and medical cannabis, and in June 2023, we published a new Cochrane review of their effects. Here's one of the authors, Andrew Moore, a retired scientist formerly at the University of Oxford speaking from the depths of Devon in the UK, to tell us about the review's findings.